Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00003658
DRKS00003658
Completed
Phase 2

Stereotactic fraktionated radiotherapy in patients with medically inoperable small lung tumors (STRIPE I): a phase II study - STRIPE I

niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde0 sites102 target enrollmentApril 18, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsC34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lung

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
C34
Sponsor
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Enrollment
102
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2012
End Date
November 26, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde

Eligibility Criteria

Inclusion Criteria

  • •presence of one or two FDG\-PET positive pulmonary nodules \- Karnofsky index \>/\= 60%
  • •\- Life expectancy \> 6 months
  • •\- Age \> 18 years (no other age limits)
  • •\- Informed consent signed in accordance with institutional protocol

Exclusion Criteria

  • •\- NSCLC: FDG\-PET N\+ if not ruled out by mediastinoscopy or other tissue sampling
  • •\- in metastases: disseminated progressive disease without local control to be reasonably expected by current treatment
  • •\- Histologically proven SCLC
  • •\- More than two lesions to treat
  • •\- Diameter of tumor \> 5cm
  • •\- Systemic therapy \+/\- one week of treatment
  • •\- psychological/mental status does not allow informed consent and participation in QoL assessments
  • •\- Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Stereotactic fractionated radiotherapy of the resection cavity as adjuvant treatment after resection of brain metastasesC71Malignant neoplasm of brain
DRKS00009357niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde60
Recruiting
Phase 2
EO-TACTICS trialBrain metastase
JPRN-jRCTs042220014Mitsuya Koichi57
Recruiting
Phase 1
Fractionated stereotactic radiotherapy plus second-generation antiandrogen for oligometastatic patients with castration-resistant prostate cancer. Phase II Spanish study, prospective, multicenter. (OLIGORESIST)Oligometastatic patients with castration-resistant prostate cancerTherapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2023-505024-62-01Instituto de investigación en Oncología radioterápica FEOR (Fundación Española de Oncología RT)51
Completed
Phase 2
Hypofractionated stereotactic radiotherapy for large brain metastasesBrain metastases
JPRN-UMIN000010112Department of Radiology, Nagoya City University Graduate School of Medical Sciences90
Recruiting
Not Applicable
Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain MetastasesBrain MetastasesResection Cavity
NCT05160818Technical University of Munich126